Kathiresan Sekar
SEC insider (Form 3/4/5 filer). CIK 0001864112. Director at Maze Therapeutics, Inc. (MAZE) and 2 other issuers. 22 reported Form 4/5 transactions since Sep 2024; latest on Sep 22, 2025. Located in BOSTON, MA.
Companies Kathiresan Sekar has filed insider reports for
- Maze Therapeutics, Inc. (MAZE): Director
- Verve Therapeutics, Inc. (VERV): Director, Officer, Chief Executive Officer
- Relay Therapeutics, Inc. (RLAY): Director
Kathiresan Sekar
CIK: 0001864112
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Sep 22, 2025MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectRestricted Stock Units
99K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferIndirect111K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferDirect348.4K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferIndirect241K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectRestricted Stock Units
120K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
139K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
488K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
150K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
167.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 22, 2025 |  MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| Jul 25, 2025 |  VERV Verve Therapeutics, Inc. | Disposition Restricted Stock Units | 99,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Tender Offer | 110,997 | - | - | Indirect |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Tender Offer | 348,431 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Tender Offer | 240,997 | - | - | Indirect |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Restricted Stock Units | 120,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 138,995 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 488,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 150,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 167,425 | - | - | Direct |
1-10 of 22 transactions